END STAGE RENAL DISEASE
Clinical trials for END STAGE RENAL DISEASE explained in plain language.
Never miss a new study
Get alerted when new END STAGE RENAL DISEASE trials appear
Sign up with your email to follow new studies for END STAGE RENAL DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Blood test aims to balance infection and rejection risks in kidney transplants
Disease control TerminatedThis study looked at whether a blood test called ImmuKnow can help doctors better manage anti-rejection drugs in kidney transplant patients. The goal was to reduce infections while still preventing organ rejection. Only 4 patients were enrolled before the study was stopped early,…
Matched conditions: END STAGE RENAL DISEASE
Phase: PHASE4 • Sponsor: CAMC Health System • Aim: Disease control
Last updated Jun 17, 2026 12:09 UTC
-
New hope for kidney patients with Hard-to-Match immune systems
Disease control TerminatedThis study tested two drugs, daratumumab and belatacept, in 5 highly sensitized dialysis patients waiting for a kidney transplant. The goal was to safely reduce the antibodies that make it very hard to find a compatible donor kidney. The trial was stopped early, but it aimed to h…
Matched conditions: END STAGE RENAL DISEASE
Phase: PHASE2 • Sponsor: University Hospital, Grenoble • Aim: Disease control
Last updated Jun 15, 2026 19:03 UTC
-
Dialysis showdown: which type helps kidney patients live longer?
Knowledge-focused TerminatedThis study compared survival rates between two common dialysis methods—peritoneal dialysis and hemodialysis—in 416 adults with end-stage kidney disease in China. Researchers tracked deaths, complications, and quality of life to see if one method offered better outcomes. The study…
Matched conditions: END STAGE RENAL DISEASE
Phase: NA • Sponsor: Vantive Health LLC • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:03 UTC